These results were expected, given that the U87MG genome had a relatively smaller number of ‘lost’ CpGs compared to the CAST genome; furthermore, as the cancer sample had a low starting methylation, the effect of 0%-methylated sites on the mean would naturally be smaller. This evidence concerns the gene CAST and cancer.